 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Heffernan Michael Thomas
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-07-15 Sale | 2019-07-17 4:22 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 25,000 | $11.26 | $281,500 | 132,069 (Direct) | View |
| 2019-06-17 Sale | 2019-06-19 6:05 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 25,000 | $11.37 | $284,246 | 159,090 (Direct) | View |
| 2019-05-15 Sale | 2019-05-17 4:04 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 25,000 | $12.84 | $321,042 | 188,586 (Direct) | View |
| 2019-05-09 Purchase | 2019-05-13 5:01 pm | Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director | 2,500 | $10 | $25,000 | 6,351 (Direct) | View |
| 2019-04-15 Sale | 2019-04-17 4:24 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 25,000 | $15.09 | $377,366 | 207,170 (Direct) | View |
| 2019-03-15 Sale | 2019-03-19 5:36 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 25,000 | $17.17 | $429,250 | 227,362 (Direct) | View |
| 2019-02-15 Sale | 2019-02-20 4:17 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 25,000 | $14.81 | $370,224 | 259,430 (Direct) | View |
| 2019-01-15 Sale | 2019-01-17 4:16 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 25,000 | $15.56 | $389,000 | 286,000 (Direct) | View |
| 2018-12-17 Sale | 2018-12-18 5:09 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 25,000 | $18.18 | $454,491 | 314,313 (Direct) | View |
| 2018-11-15 Sale | 2018-11-16 4:19 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 25,000 | $16.6 | $415,122 | 339,600 (Direct) | View |
| 2018-10-15 Sale | 2018-10-17 4:27 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 25,000 | $16.53 | $413,250 | 361,000 (Direct) | View |
| 2018-06-11 Sale | 2018-06-13 4:56 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman | 150,000 | $25.27 | $3,790,939 | 441,750 (Direct) | View |
| 2018-05-10 Sale | 2018-05-14 4:32 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman | 7,100 | $26.21 | $186,100 | 540,193 (Direct) | View |
| 2018-04-19 Sale | 2018-04-23 5:05 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman | 44,400 | $26 | $1,154,401 | 545,893 (Direct) | View |
| 2018-01-22 Sale | 2018-01-23 5:41 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman | 3,592 | $25 | $89,800 | 535,395 (Direct) | View |
| 2018-01-19 Sale | 2018-01-19 5:41 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman | 20,000 | $22.5 | $450,000 | 538,987 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-08-09 Tax Withholding | 2019-08-13 4:45 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 4,779 | $11.24 | 126,623 (Direct) | View |
| 2019-07-19 Tax Withholding | 2019-07-23 4:03 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 667 | $10.35 | 131,402 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 4:04 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director | 13,700 | $0 | 21,186 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 4:04 pm | 2020-06-06 2029-06-06 | Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director | 20,100 | $4.23 | 21,186 (Direct) | View |
| 2019-05-09 Conversion | 2019-05-13 5:01 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director | 3,851 | $0 | 6,351 (Direct) | View |
| 2019-05-09 Conversion | 2019-05-13 5:01 pm | N/A N/A | Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director | 34,247 | $0 | 6,351 (Direct) | View |
| 2019-05-07 Option Award | 2019-05-08 5:01 pm | N/A 2029-05-06 | Trevi Therapeutics Inc. | TRVI | Heffernan Michael Thomas Director | 23,684 | $10 | 23,684 (Direct) | View |
| 2019-04-25 Option Award | 2019-04-30 08:52 am | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 4,707 | $0 | 207,069 (Direct) | View |
| 2019-04-25 Option Award | 2019-04-30 08:52 am | N/A 2029-04-25 | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 9,414 | $14.57 | 207,069 (Direct) | View |
| 2019-02-08 Tax Withholding | 2019-02-11 5:06 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 7,851 | $14.39 | 277,362 (Direct) | View |
| 2019-01-18 Tax Withholding | 2019-01-23 4:14 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 787 | $15.76 | 285,213 (Direct) | View |
| 2018-12-12 Option Award | 2018-12-13 6:38 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director | 7,486 | $0 | 25,000 (Direct) | View |
| 2018-12-12 Option Award | 2018-12-13 6:38 pm | N/A 2026-06-21 | Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director | 18,716 | $16.17 | 25,000 (Direct) | View |
| 2018-12-12 Option Award | 2018-12-13 6:38 pm | N/A 2027-06-09 | Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director | 11,229 | $17.53 | 25,000 (Direct) | View |
| 2018-12-12 Option Award | 2018-12-13 6:38 pm | N/A 2028-06-30 | Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director | 11,229 | $10.05 | 25,000 (Direct) | View |
| 2018-12-12 Option Award | 2018-12-13 6:38 pm | N/A 2028-12-12 | Akebia Therapeutics Inc. | AKBA | Heffernan Michael Thomas Director | 25,000 | $8.94 | 25,000 (Direct) | View |
| 2018-12-12 Disposition | 2018-12-13 4:35 pm | N/A N/A | KERYX BIOPHARMACEUTICALS INC | KERX | Heffernan Michael Thomas Director | 20,000 | $0 | 0 (Direct) | View |
| 2018-12-12 Disposition | 2018-12-13 4:35 pm | N/A N/A | KERYX BIOPHARMACEUTICALS INC | KERX | Heffernan Michael Thomas Director | 110,000 | $0 | 0 (Direct) | View |
| 2018-08-23 Tax Withholding | 2018-08-27 4:06 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 2,025 | $18.03 | 386,000 (Direct) | View |
| 2018-08-03 Tax Withholding | 2018-08-06 5:41 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 668 | $20.15 | 388,025 (Direct) | View |
| 2018-06-30 Option Award | 2018-07-12 5:59 pm | N/A N/A | KERYX BIOPHARMACEUTICALS INC | KERX | Heffernan Michael Thomas Director | 10,000 | $0 | 30,000 (Direct) | View |
| 2018-06-30 Option Award | 2018-07-12 5:59 pm | 2019-06-30 2028-06-30 | KERYX BIOPHARMACEUTICALS INC | KERX | Heffernan Michael Thomas Director | 30,000 | $3.76 | 30,000 (Direct) | View |
| 2018-02-26 Tax Withholding | 2018-03-01 4:04 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman | 4,050 | $21.77 | 590,193 (Direct) | View |
| 2018-02-05 Tax Withholding | 2018-02-06 4:14 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman | 788 | $23.38 | 594,243 (Direct) | View |
| 2018-01-25 Option Award | 2018-01-29 7:41 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman | 75,000 | $0 | 595,031 (Direct) | View |
| 2018-01-25 Option Award | 2018-01-29 7:41 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman | 1,044 | $10.17 | 595,031 (Direct) | View |
| 2018-01-25 Option Award | 2018-01-29 7:41 pm | N/A 2028-01-25 | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman | 150,000 | $24.35 | 595,031 (Direct) | View |
| 2018-01-22 Sale | 2018-01-23 5:41 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas CEO, Chairman | 16,408 | $25.01 | 535,395 (Direct) | View |